Is it legal to sell peptides in the US?

On this page

1. The short answer
2. How federal law decides what a peptide is
3. What "research use only" does, and what it does not
4. What the FDA has actually enforced
5. Do you need a license to sell peptides?
6. Supplements, cosmetics and approved drugs are different categories
7. Advertising rules: the FTC side
8. Payment networks and platforms set their own rules
9. A compliance checklist for a research peptide store

Whether it is legal to sell peptides in the US depends far less on the peptide than on how you sell it: what your label says, what your website and marketing claim, who you sell to and what you sell alongside it. This guide explains how federal law draws that line, what the FDA has actually enforced against peptide sellers, and what a careful seller does about it. It is written for founders selling research peptides, including through white label peptides programs like ours. It is general information, not legal advice.

The short answer

There is no federal law that bans selling peptides as such, and there is also no "research use only" loophole. Peptides sold as research chemicals for laboratory research occupy a legal space that holds only as long as everything about the sale is consistent with research use. If your product, label, website, marketing or customer messages show that it is intended for use in people, federal law treats it as a drug, and selling an unapproved drug is illegal regardless of any disclaimer on the vial.

How federal law decides what a peptide is

The Federal Food, Drug, and Cosmetic Act defines a drug largely by its intended use: articles intended for the diagnosis, cure, mitigation, treatment or prevention of disease, and articles (other than food) intended to affect the structure or any function of the body. The same molecule can therefore be a research reagent in one sale and an unapproved drug in another.

The FDA's regulation on intended use (21 CFR 201.128) says intent is judged objectively, from the seller's own expressions, the design of the product, and the circumstances surrounding its distribution. That includes labeling claims, advertising, and oral or written statements by the seller or anyone speaking for it. In plain terms, the FDA reads everything: your product pages, your blog, your emails, your social posts, your chat replies and what you bundle with the product.

What "research use only" does, and what it does not

A research-use statement is necessary. It tells buyers, payment providers and regulators what the product is for, and a seller without one has a harder time arguing research intent at all. But it is not sufficient. When the rest of the sale points to human use, the FDA treats the statement as contradicted rather than protective.

"Despite statements on your product labeling marketing your products for 'Research Use Only,' and 'not intended for human consumption, medical use, or veterinary use,' evidence obtained from your website establishes that your products are intended to be drugs for human use."

FDA warning letter to an online peptide seller, March 31, 2026

What the FDA has actually enforced

The FDA has been writing to online peptide sellers directly. On March 31, 2026 its drug center sent a warning letter to an online peptide seller, quoted above. On August 24, 2026 the same center issued warning letters to five more online peptide vendors, each alleging the sale of unapproved new drugs after the agency reviewed their websites. The pattern in what the agency cited is consistent:

• Claims about effects in the body, such as appetite, weight, metabolism, healing or performance.
• Dosing and preparation information, such as protocols and reconstitution instructions.
• Injection supplies sold alongside the product, which the agency has cited as evidence of intended human use.
• Marketing that speaks to personal use rather than laboratory research.

The statutory basis in these letters is the introduction of unapproved new drugs into interstate commerce (sections 505(a) and 301(d) of the Act). A warning letter is not a penalty in itself, but it is public, it is read by payment processors and banks, and ignoring one can lead to seizures, injunctions and prosecution.

Do you need a license to sell peptides?

There is no federal license that makes it legal to sell a peptide for human use without FDA approval, and there is no specific federal license for selling research peptides. What you do need is ordinary: a registered business, sales tax registration where you owe it, and any state-level permits that apply to your activity. Some states have their own rules on drugs, chemicals or online sales, so check the states you ship to.

Licenses do matter in the neighboring businesses. Dispensing peptides to patients requires a prescriber and a licensed pharmacy, and compounding pharmacies operate under their own federal and state rules, including limits on which bulk substances they may use. If your model involves patients or prescriptions, you are in that world, not the research market.

Supplements, cosmetics and approved drugs are different categories

Some peptide products are sold legally in other categories under other rules. Approved peptide drugs are sold by prescription. Some ingredients, such as collagen peptides, are sold as food or dietary supplement ingredients. Skincare can contain peptides as cosmetic ingredients, but a cosmetic that claims to change the body's structure or function is treated as a drug. None of these categories can be reached by relabeling a research peptide: each has its own manufacturing, labeling and approval requirements.

Advertising rules: the FTC side

The Federal Trade Commission polices advertising. Its health products guidance says health-related claims need competent and reliable scientific evidence, and that the rules cover every claim an ad conveys, including implied claims, influencer posts and customer testimonials you promote. For a research peptide seller the practical rule is simple: make no health claims at all, and do not repost or encourage anyone else's.

Payment networks and platforms set their own rules

Even a carefully compliant seller has to satisfy private gatekeepers. Visa's Integrity Risk Program, in force since May 2023, puts merchants in categories it considers high risk under registration and monitoring by their acquiring bank, and pharmaceutical and drug-adjacent sellers fall under that scrutiny. Many mainstream payment providers restrict pseudo-pharmaceutical products in their own terms, and several large ecommerce platforms do too. These rules are contractual, not criminal, but losing a processor or a store can end a business faster than a regulator. Our guide on how to sell peptides online covers platforms and payments.

A compliance checklist for a research peptide store

• Every label and product page says research use only, not for human consumption.
• No claims about what any product does in or for a person, anywhere on your site or channels.
• No dosing, preparation or administration information, including in chat and email replies.
• Nothing in your catalog, bundles or images that signals human use.
• Batch-specific lab reports, with batch numbers that match the vials.
• Terms of sale that restrict sales to research use, and a buyer acknowledgement at checkout.
• Reviews and testimonials moderated so they do not describe personal use or effects.
• Affiliates and creators bound by the same rules in writing.
• A lawyer who knows FDA and FTC rules has reviewed your site before launch.

In our program, every brand agrees to keep its labels, site and marketing research-use only, and a pre-launch website compliance review is available as an add-on.

Sources

1. eCFR: 21 CFR 201.128, Meaning of intended uses
2. 21 U.S.C. 321, definitions (drug), Legal Information Institute
3. FDA warning letter to Gram Peptides, March 31, 2026
4. ArentFox Schiff: five peptide vendors learn that research use only is not a legal strategy
5. FTC: Health Products Compliance Guidance (2022)
6. PaymentCloud: guide to the Visa Integrity Risk Program